
Adaptive Biotechnologies Corporation ADPT
$ 15.14
-3.2%
Quarterly report 2025-Q3
added 11-05-2025
Adaptive Biotechnologies Corporation P/E Ratio 2011-2026 | ADPT
Annual P/E Ratio Adaptive Biotechnologies Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.39 | -2.65 | -6.13 | -9.77 | -50.8 | -31.1 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.65 | -50.8 | -18 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Amarin Corporation plc
AMRN
|
-7.45 | $ 14.58 | -2.93 % | $ 5.94 B | ||
|
Aptorum Group Limited
APM
|
-0.958 | $ 0.82 | -2.71 % | $ 4.47 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-2.63 | $ 2.99 | 0.17 % | $ 168 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.48 | -0.78 % | $ 8.37 B | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Athira Pharma
ATHA
|
-0.167 | - | - | $ 269 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 9.14 | -1.14 % | $ 1.47 B | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 217.62 | -2.93 % | $ 5 B | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Codexis
CDXS
|
-4.46 | $ 1.2 | -4.4 % | $ 88.1 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.136 | - | 17.91 % | $ 11.1 M | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
6.11 | $ 108.91 | -0.02 % | $ 27.2 B | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
Baudax Bio
BXRX
|
-0.0133 | - | 0.59 % | $ 63 K | ||
|
Cabaletta Bio
CABA
|
-0.303 | $ 2.54 | -2.38 % | $ 2.97 M | ||
|
Calithera Biosciences
CALA
|
-8.34 | - | -10.95 % | $ 876 K | ||
|
Autolus Therapeutics plc
AUTL
|
-1.92 | $ 1.4 | -2.45 % | $ 357 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-24.7 | $ 14.71 | -0.34 % | $ 4.55 B | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 4.28 | -1.34 % | $ 9.31 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M |